 |
市场调查报告书
商品编码
1550554
止痛药的全球市场：按药物类型、按给药途径、按应用、按疼痛类型、按分销管道、按地区Global Analgesics Market, By Drug Type, By Route of Administration, By Application, By Pain Type, By Distribution Channel, By Geography |
||||||
预计2024年全球止痛药市场规模将达511亿美元，2024年至2031年复合年增长率为6.5%，2031年将达795.1亿美元。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 511亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 6.50% | 2031 年金额预测 | 795.1亿美元 |
全球止痛药市场的成长是由世界各地慢性和急性疼痛疾病的增加所推动的。镇痛药在缓解疼痛和改善患者生活品质方面发挥重要作用。生活方式的改变和压力水平的增加导致背痛、关节炎和偏头痛等与疼痛相关的疾病显着增加。药物输送系统和製剂开发的技术进步正在增加对具有更高疗效和降低成瘾风险的新型止痛药的需求。此外，老年人口的增加，更容易患骨关节炎和肌肉骨骼疾病，也是推动止痛药需求的因素。然而，围绕阿片类药物的严格监管和替代疗法的开发可能给行业相关人员带来挑战。
市场动态：
全球止痛药市场的成长主要是由于全球老年人口的不断增加，导致关节炎、下背痛、偏头痛和骨质疏鬆症等各种与疼痛相关的慢性疾病的盛行率不断上升。据估计，到 2030 年，世界上超过 20% 的人口将受到骨关节炎的影响。久坐工作和压力增加等生活方式的改变显着增加了肌肉骨骼疾病的发生率，从而推动了对止痛药的需求。然而，对处方阿片类药物滥用和滥用的日益担忧可能会阻碍市场成长。这导致监管机构收紧了阿片类止痛药的核准和使用规则。此外，大麻素药物、针灸和物理治疗等替代疗法越来越受欢迎，这可能会抑制对传统止痛药的需求。慢性疼痛管理的优惠报销政策为止痛药製造商提供了商机。继续研究开发非成瘾配方和先进的药物输送系统可能会提供未来的成长机会。
本研究的主要特点
该报告对全球止痛药市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球止痛药市场的主要企业。
主要公司包括辉瑞（Pfizer）、葛兰素史克（GSK）、诺华（Novartis）和强生（Johnson & Johnson）。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球止痛市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球止痛药市场的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规及趋势分析
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 影响分析
- 市场趋势
- 主要进展
- 监管场景
- 收购和合作场景
- 资金筹措和投资
- PEST分析
- 波特的分析
第四章全球止痛药市场－COVID-19 的影响
- 整体影响
- 政府倡议
- COVID-19 对市场的影响
第五章全球镇痛药市场，依药物类型，2019-2031（十亿美元）
- 阿片类药物
- 非阿片类药物
- 复方药物
第六章 全球止痛药市场，依给药途径，2019-2031 年（十亿美元）
- 口服
- 胃肠外的
- 经皮的
- 其他的
第七章 全球镇痛药市场，依应用分类，2019-2031（十亿美元）
- 肌肉骨骼
- 手术/外伤
- 癌症
- 神经病变
- 偏头痛
- 产科
- 纤维肌痛
- 烧烫伤引起的疼痛
- 牙科/脸部护理
- 小儿科
- 其他的
第八章全球镇痛药市场，依疼痛类型，2019-2031（十亿美元）
- 急性
- 慢性的
第 9 章 全球止痛市场，依通路划分，2019-2031 年（十亿美元）
- 医院药房
- 零售药房
- 网路药房
第10章全球镇痛市场，按地区，2019-2031（十亿美元）
- 拉丁美洲
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 欧洲其他地区
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中部非洲
- 南非
第十一章竞争格局
- 公司简介
- F. Hoffmann-La Roche Ltd.
- Mylan NV
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck &Co., Inc.
- AstraZeneca
- Johnson &Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin
第十二章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会图
第十三章参考文献与调查方法
- 参考
- 调查方法
Global analgesics market is estimated to be valued at USD 51.10 Bn in 2024 and is expected to reach USD 79.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 51.10 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.50% | 2031 Value Projection: | US$ 79.51 Bn |
Global analgesics market growth is driven by rising prevalence of chronic and acute pain disorders worldwide. Analgesics drugs play a crucial role in relieving pain and enhancing the quality of life of patients. Changing lifestyles and higher stress levels have significantly increased several pain-related ailments like backache, arthritis, and migraines among others. Technological advancements in drug delivery systems and formulation development have boosted demand for novel analgesic medications with improved efficacy and reduced risk of addiction. Moreover, growing geriatric population prone to osteoarthritis and musculoskeletal disorders can also boost demand for analgesics. However, strict regulations surrounding opioid medications and development of alternative therapies can pose challenges to industry players.
Market Dynamics:
Global analgesics market growth is primarily driven by rising prevalence of various pain-related chronic conditions like arthritis, back pain, migraines, and osteoporosis due to growing geriatric population worldwide. As per estimates, over 20% of the global population will suffer from osteoarthritis by 2030. Changing lifestyles with sedentary jobs and increased stress levels have substantially raised the incidence of musculosketal disorders, thus, boosting demand for analgesic. However, growing concerns over misuse and abuse of prescription opioids can hamper the market growth. This has led regulatory bodies to tighten rules surrounding opioid analgesic approvals and usage. Moreover, alternative therapies like cannabinoid-based drugs, acupuncture, and physiotherapy are gaining popularity, and this can hamper demand for traditional painkillers. Favorable reimbursement policies for chronic pain management provides profitable opportunities for analgesic manufacturers. Ongoing research towards develop non-addictive formulas and advanced drug delivery systems can offer growth opportunities in the future.
Key Features of the Study:
This report provides in-depth analysis of the global analgesics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global analgesics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer, GSK, Novartis, and Johnson & Johnson.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global analgesics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global analgesics market
Detailed Segmentation-
- By Drug Type
- Opioid
- Non-opioid
- Compound medication
- By Route of Administration
- Oral
- Parenteral
- Transdermal
- Others
- By Application
- Musculoskeletal
- Surgical and Trauma
- Cancer
- Neuropathic
- Migraine
- Obstetrical
- Fibromyalgia
- Pain due to Burns
- Dental/Facial
- Pediatric
- Others
- By Pain Type
- Acute
- Chronic
- By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- F. Hoffmann-La Roche Ltd.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Pain Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Analgesics Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Analgesics Market, By Drug Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Opioid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Non-opioid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Compound medication
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Analgesics Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Transdermal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Analgesics Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Musculoskeletal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Surgical and Trauma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neuropathic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Migraine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Obstetrical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Fibromyalgia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pain due to Burns
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Dental/Facial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Pediatric
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Analgesics Market, By Pain Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Acute
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Chronic
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Analgesics Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
- Hospital pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
10. Global Analgesics Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Pain Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
11. Competitive Landscape
- Company Profiles
- F. Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Private Limited
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Aurobindo Pharma
- Bausch Health Companies Inc.
- Amneal Pharmaceuticals LLC.
- Apotex Inc.
- Eli Lilly and Company
- Cipla Inc.
- Lupin
- F. Hoffmann-La Roche Ltd.
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
可待因市场：按配方、等级、应用、分销管道、最终用户划分 - 2025-2030 年全球预测
全球镇痛药市场评估：依药物类别、给药途径、应用、通路、地区、机会、预测（2017-2031）
全球非处方镇痛药市场评估：按药物类型、给药途径、分销管道、地区、机会和预测（2017-2031）
阿片类镇痛药市场评估：按产品类型、应用、给药途径、分销管道和地区划分的机会和预测（2017-2031）
Tapentadol市场：按应用程式、最终用户划分 - 全球预测 2025-2030
镇痛药物市场：按药物类型、类型、给药途径、分布划分 - 全球预测 2025-2030
Antipilin 市场：按产品类型、应用、最终用户、分销管道、年龄层、治疗层级- 2025-2030 年全球预测
Butorphanol市场：按产品类型、应用和分销管道划分 - 全球预测 2025-2030
阿斯匹灵市场：按产品、包装、剂型、剂量、分销管道和最终用户 - 2025-2030 年全球预测
2024-2032 年按治疗类别、配方、类型（处方止痛药、非处方止痛药）、配销通路和地区分類的局部止痛市场报告